Lv11
34 积分 2023-05-05 加入
Sensitization of EGFR Wild-Type Non–Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib
2天前
已完结
EGFR targeting PhosTACs as a dual inhibitory approach reveals differential downstream signaling
15天前
已完结
20 years since the approval of first EGFR-TKI, gefitinib: Insight and foresight
16天前
已完结
Recent Advances on the Role of EGFR Tyrosine Kinase Inhibitors in the Management of NSCLC With Uncommon, Non Exon 20 Insertions, EGFR Mutations
16天前
已完结
Chemical Genetics Reveals a Role of Squalene Synthase in TGFβ Signaling and Cardiomyogenesis
18天前
已完结
Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer
19天前
已完结
Carrier‐free nanodrugs for stemness inhibition‐enhanced photodynamic therapy
21天前
已完结
Emerging strategies to investigate the biology of early cancer
22天前
已完结
Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting
22天前
已完结
Platinum(IV) Prodrugs with Cancer Stem Cell Inhibitory Effects on Lung Cancer for Overcoming Drug Resistance
22天前
已完结
皖公网安备34019202002308
